rs1352254279

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP7BS2

The NM_001388447.1(PABIR3):​c.684G>A​(p.Val228Val) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,100,184 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000010 ( 0 hom. 3 hem. )

Consequence

PABIR3
NM_001388447.1 splice_region, synonymous

Scores

1
1
15
Splicing: ADA: 0.00003792
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0910

Publications

0 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10648039).
BP7
Synonymous conserved (PhyloP=0.091 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.684G>A p.Val228Val splice_region_variant, synonymous_variant Exon 10 of 11 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.684G>A p.Val228Val splice_region_variant, synonymous_variant Exon 10 of 11 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.00000895
AC:
1
AN:
111716
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000101
AC:
10
AN:
988468
Hom.:
0
Cov.:
21
AF XY:
0.0000101
AC XY:
3
AN XY:
296684
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23245
American (AMR)
AF:
0.00
AC:
0
AN:
22060
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17524
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25818
South Asian (SAS)
AF:
0.00
AC:
0
AN:
43018
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3912
European-Non Finnish (NFE)
AF:
0.0000127
AC:
10
AN:
784377
Other (OTH)
AF:
0.00
AC:
0
AN:
42288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000895
AC:
1
AN:
111716
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33900
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30757
American (AMR)
AF:
0.00
AC:
0
AN:
10425
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3599
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2717
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5916
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53231
Other (OTH)
AF:
0.00
AC:
0
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 05, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.440G>A (p.C147Y) alteration is located in exon 6 (coding exon 6) of the FAM122C gene. This alteration results from a G to A substitution at nucleotide position 440, causing the cysteine (C) at amino acid position 147 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.15
DANN
Benign
0.95
DEOGEN2
Benign
0.019
T
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.34
T
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.091
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.057
Sift
Uncertain
0.022
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.32
MutPred
0.28
Loss of methylation at K144 (P = 0.0556);
MVP
0.80
MPC
0.83
ClinPred
0.16
T
GERP RS
1.1
Varity_R
0.18
gMVP
0.19
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000038
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1352254279; hg19: chrX-133986924; API